Login / Signup
Ruxolitinib bridging therapy to allogeneic SCT for high-risk refractory subcutaneous panniculitis-like T-cell lymphoma.
Leisa R Watson
Thomas E Lew
Lucy Claire Fox
Amit Khot
Carrie van der Weyden
Published in:
Leukemia & lymphoma (2022)
Keyphrases
</>
stem cell transplantation
bone marrow
high dose
mesenchymal stem cells